CDY
Click for more information
1.43% 7.1¢ cellmid limited

2018 - The Year of the BioTechs, page-607

  1. Pharmargeddon
    1,750 Posts.
    lightbulb Created with Sketch. 132
    clock Created with Sketch.
    24/06/18
    08:43
    Post #: 33908541
    This may help:
    From the Investor Presentation.

    Advangen revenue ($m, June YE)
    FY2017 revenue by region

    USA was at 3% for last years FY
    Be interesting to see what it is for this one.
    CDY Price at posting: 48.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS $6.2 million Government Grant secured by Hazer to progress technology commercialisation
right-arrow Created with Sketch.
NEWS Thrilling study results take Orthocell a step closer to FDA clearance
right-arrow Created with Sketch.
NEWS Breaking news: HotCopper now open to capital raising!
right-arrow Created with Sketch.
NEWS OVD027 intercepts massive sulphide creating continued optimism
right-arrow Created with Sketch.
RMS Flicka Lake Project enters promising new era as highly encouraging results found
right-arrow Created with Sketch.
NEWS Peppermint looks to elevate AI and data transformation
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.